Evidence map›Paper›PMID 31536501›Full record

ArticlePloS one2019

Pathogen invasion history elucidates contemporary host pathogen dynamics.

Vance T Vredenburg, Samuel V G McNally, Hasan Sulaeman, Helen M Butler, Tiffany Yap, Michelle S Koo, Dirk S Schmeller, Celeste Dodge, Tina Cheng, Gordon Lau and 1 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tracking, Synthesizing, and Sharing GlobalFrontiers in veterinary science · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vance T VredenburgDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0002-9682-1190
Samuel V G McNallyDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.
Hasan SulaemanDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0002-3061-2185
Helen M ButlerDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.
Tiffany YapDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.
Michelle S KooMuseum of Vertebrate Zoology, University of California Berkeley, Berkeley, California, United States of America.
Dirk S SchmellerEcoLab, Université de Toulouse, Toulouse, France.ORCID 0000-0002-3860-9933
Celeste DodgeDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0003-0932-1911
Tina ChengDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.ORCID 0000-0002-7930-8635
Gordon LauDepartment of Biology, San Francisco State University, San Francisco, California, United States of America.
Cheryl J BriggsDepartment of Ecology Evolution and Marine Biology, University of California Santa Barbara, Santa Barbara, California, United States of America.ORCID 0000-0001-8674-5385

Funding

EID disease in complex communities: multi-host multi-pathogen interactionsR01GM109499 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI BRIGGS, CHERYL J · 2013 to 2016
$1.7M
NIGMS NIH HHS R01 GM109499
6 · The paper itself

Abstract

Amphibians, the most threatened group of vertebrates, are seen as indicators of the sixth mass extinction on earth. Thousands of species are threatened with extinction and many have been affected by an emerging infectious disease, chytridiomycosis, caused by the fungal pathogen, Batrachochytrium dendrobatidis (Bd). However, amphibians exhibit different responses to the pathogen, such as survival and population persistence with infection, or mortality of individuals and complete population collapse after pathogen invasion. Multiple factors can affect host pathogen dynamics, yet few studies have provided a temporal view that encompasses both the epizootic phase (i.e. pathogen invasion and host collapse), and the transition to a more stable co-existence (i.e. recovery of infected host populations). In the Sierra Nevada mountains of California, USA, conspecific populations of frogs currently exhibit dramatically different host/ Bd-pathogen dynamics. To provide a temporal context by which present day dynamics may be better understood, we use a Bd qPCR assay to test 1165 amphibian specimens collected between 1900 and 2005. Our historical analyses reveal a pattern of pathogen invasion and eventual spread across the Sierra Nevada over the last century. Although we found a small number of Bd-infections prior to 1970, these showed no sign of spread or increase in infection prevalence over multiple decades. After the late 1970s, when mass die offs were first noted, our data show Bd as much more prevalent and more spatially spread out, suggesting epizootic spread. However, across the ~400km2 area, we found no evidence of a wave-like pattern, but instead discovered multiple, nearly-simultaneous invasions within regions. We found that Bd invaded and spread in the central Sierra Nevada (Yosemite National Park area) about four decades before it invaded and spread in the southern Sierra Nevada (Sequoia and Kings Canyon National Parks area), and suggest that the temporal pattern of pathogen invasion may help explain divergent contemporary host pathogen dynamics.

Indexed as

ChytridiomycotaHost-Pathogen InteractionsAmphibiansAnimal DiseasesAnimalsCaliforniaMuseumsMycosesNevada

Identifiers

PMID31536501
PMCPMC6752790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.